The following adverse effects were reported in patients receiving semaglutide injection or oral tablets across all clinical trials and at incidences higher than with placebo: nausea (11% to 44%), vomiting (5% to 24%), diarrhea (8.5% to 30%), abdominal pain (5.7% to 20%), abdominal distention (2% to 7%), constipation (3.1% to 24%), dyspepsia (0.6% to 9%), decreased appetite (6% to 9%), eructation (0.6% to 7%), flatulence (0.4% to 6%), gastroesophageal reflux disease (1.5% to 5%), gastroenteritis (4% to 6%), and gastritis (0.4% to 4%)
Synthetic GLP-1 analogs like semaglutide, liraglutide, and tirzepatide are engineered to resist breakdown, providing longer-lasting effects with once-weekly or once-daily dosing
This educational content is provided by The Peptide Guide for informational and educational purposes only and does not constitute medical advice, diagnosis, or treatment
Because PT-141 acts centrally rather than via the vasculature, some providers may use it alongside other treatments when appropriate
Packed into the Shred Energy Drink is a light 113mg of caffeine and B vitamins for energy, then filling out the other side is chromium, green tea extract, and a bit of chromium in 300mg each of acetyl and carnitine tartrate